Yu Fukase

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

Noriaki Sawada, T Ishikawa, Yu Fukase et al. · PubMed · 1998 · 425 citations

Capecitabine Efficacy, Human Cancer Xenografts, Cancer Biology +16

Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts

Tohru Ishikawa, Masahiro Utoh, Noriaki Sawada et al. · Biochemical Pharmacology · 1998 · 329 citations

Oncology, Polymer-drug Conjugate, Medicine +10

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.

Tohru Ishikawa, Fumiko Sekiguchi, Yu Fukase et al. · PubMed · 1998 · 304 citations

Chemoprevention Strategy, Pathology, Human Cancer Xenografts +16

Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5?-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models

Mika Endo, Noriko Shinbori, Yu Fukase et al. · International Journal of Cancer · 1999 · 129 citations · Full text

Tumor Biology, Breast Oncology, Oncology +15

Antitumor Activities of a Novel Fluoropyrimidine, N4-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (Capecitabine).

Tohru Ishikawa, Yu Fukase, Taeko Yamamoto et al. · Biological and Pharmaceutical Bulletin · 1998 · 55 citations · Full text

Chemoprevention Strategy, Pathology, Ordinary Sensitivity +16